Pregnancy and multiple sclerosis from a neurologist's point of view

被引:0
|
作者
Hradilek, P. [1 ]
Meluzinova, E. [2 ]
Kovarova, I. [3 ]
机构
[1] Neurol Klin FN Ostrava, 17 Listopadu 1790, Ostrava 70852, Czech Republic
[2] LF UK & FN Motol, Neurol Klin 2, Prague, Czech Republic
[3] LF UK & VFN, Neurol Klin 1, Prague, Czech Republic
关键词
multiple sclerosis; reproduction; DMD drugs; breastfeeding; POSTPARTUM RELAPSES; INTERFERON BETA-1A; OUTCOMES; NATALIZUMAB; EXPOSURE; RISK; WOMEN; CYCLOPHOSPHAMIDE; TRIMESTER; SAFETY;
D O I
10.14735/amcsnn2018647
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Young women with reproduction potential form a major population among MS patients. The treatment of their disease should be managed regarding to possible occurrence of pregnancy. This should be planned, only thus the neurologist can adjust the treatment, so that the foetus would not be endangered by increased risk of abnormal evolution. The paper deals with the risk of individual disease modifying drugs (DMD) used for MS in early pregnancy and also during breastfeeding and brings practical recommendations for individual situations.
引用
收藏
页码:647 / 651
页数:5
相关论文
共 50 条